Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-033766
Filing Date
2025-03-05
Accepted
2025-03-05 16:48:35
Documents
1
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 8552
  Complete submission text file 0000950170-25-033766.txt   10152
Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Issuer) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address MURAL ONCOLOGY LTD. 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address
Loew Caroline (Reporting) CIK: 0001989488 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41837 | Film No.: 25712029